New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Alto Neuroscience, Inc. (ANRO) vs SpyGlass Pharma, Inc. (SGP)
- Alto Neuroscience, Inc. ANRO 25.37 −4.30%
- SpyGlass Pharma, Inc. SGP 30.43 −1.14%
Alto Neuroscience, Inc. and SpyGlass Pharma, Inc. are both Biotechnology companies. Alto Neuroscience, Inc. and SpyGlass Pharma, Inc. are of similar size ($1.1B and $1.0B). Across the 9 metrics below, Alto Neuroscience, Inc. leads on 6 and SpyGlass Pharma, Inc. on 3.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack